Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1978 Jan;40(1):35–40. doi: 10.1136/hrt.40.1.35

Electrophysiological effects of acebutolol.

J W Mason, R A Winkle, P J Meffin, D C Harrison
PMCID: PMC481971  PMID: 341930

Full text

PDF
35

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Briant R. H., Dollery C. T., Fenyvesi T., George C. F. Pharmacology of M & B 17803A in man and dog. Br J Pharmacol. 1971 Oct;43(2):468P–469P. [PMC free article] [PubMed] [Google Scholar]
  2. Cuthbert M. F., Owusu-Ankomah K. Effect of M & B 17803A, a new -adrenoceptor blocking agent, on the cardiovascular responses to tilting and to isoprenaline in man. Br J Pharmacol. 1971 Nov;43(3):639–648. doi: 10.1111/j.1476-5381.1971.tb07193.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Davis L. D., Temte J. V. Effects of propranolol on the transmembrane potentials of ventricular muscle and Purkinje fibers of the dog. Circ Res. 1968 May;22(5):661–677. doi: 10.1161/01.res.22.5.661. [DOI] [PubMed] [Google Scholar]
  4. KRAYER O., MANDOKI J. J., MENDEZ C., RUBIO G. R. Studies on veratrum alkaloids. XVI. The action of epinephrine and of veratramine on the functional refractory period of the auriculo-ventricular transmission in the heart-lung preparation of the dog. J Pharmacol Exp Ther. 1951 Dec;103(4):412–419. [PubMed] [Google Scholar]
  5. Kumana C. R., Kaye C. M., Leighton M., Turner P., Hamer J. Cardiac and pulmonary effects of acebutolol. Lancet. 1975 Jul 19;2(7925):89–93. doi: 10.1016/s0140-6736(75)90001-x. [DOI] [PubMed] [Google Scholar]
  6. Leary W. P., Coleman A. J., Asmal A. C. Respiratory effects of acebutolol hydrochloride. S Afr Med J. 1973 Jul 21;47(28):1245–1248. [PubMed] [Google Scholar]
  7. Lewis B. S., Bakst A., Kitchiner D. J., Gotsman M. S. Sectral in the management of angina pectoris. S Afr Med J. 1973 Aug 18;47(32):1455–1459. [PubMed] [Google Scholar]
  8. Lewis B. S., Bakst A., Kitchiner D., Gotsman M. S. Effectiveness of sectral (M & B 17803A) as a beta-blocking agent in man. S Afr Med J. 1973 Jul 14;47(27):1181–1184. [PubMed] [Google Scholar]
  9. McDevitt D. G., Shand D. G. Plasma concentrations and the time-course of beta blockade due to propranolol. Clin Pharmacol Ther. 1975 Dec;18(6):708–713. doi: 10.1002/cpt1975186708. [DOI] [PubMed] [Google Scholar]
  10. Meffin P. F., Harapat S. R., Harrison D. C. Quantitation in plasma and urine of acebutolol and a major metabolite with preliminary observations on their disposition kinetics in man. Res Commun Chem Pathol Pharmacol. 1976 Sep;15(1):31–51. [PubMed] [Google Scholar]
  11. Seides S. F., Josephson M. E., Batsford W. P., Weisfogel G. M., Lau S. H., Damato A. N. The electrophysiology of propranolol in man. Am Heart J. 1974 Dec;88(6):733–741. doi: 10.1016/0002-8703(74)90283-x. [DOI] [PubMed] [Google Scholar]
  12. Smithen C. S., Balcon R., Sowton E. Use of bundle of His potentials to assess changes in atrioventricular conduction produced by a series of beta-adrenergic blocking agents. Br Heart J. 1971 Nov;33(6):955–961. doi: 10.1136/hrt.33.6.955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Touboul P., Huerta F., Porte J., Delahaye J. P. Etude des propriétés électrophysiologiques de l'acébutolol chez l'homme. Therapie. 1975 May-Jun;30(3):417–427. [PubMed] [Google Scholar]
  14. Whitsitt L. S., Lucchesi B. R. Effects of beta-receptor blockade and glucagon on the atrioventricular transmission system in the dog. Circ Res. 1968 Nov;23(5):585–595. doi: 10.1161/01.res.23.5.585. [DOI] [PubMed] [Google Scholar]
  15. Williams E. M. Mode of action of beta receptor antagonists on cardiac muscle. Am J Cardiol. 1966 Sep;18(3):399–405. doi: 10.1016/0002-9149(66)90062-2. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES